136 related articles for article (PubMed ID: 26346738)
1. A Novel Microbisporicin Producer Identified by Early Dereplication during Lantibiotic Screening.
Carrano L; Abbondi M; Turconi P; Candiani G; Marinelli F
Biomed Res Int; 2015; 2015():419383. PubMed ID: 26346738
[TBL] [Abstract][Full Text] [Related]
2. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
[TBL] [Abstract][Full Text] [Related]
3. Brominated Variant of the Lantibiotic NAI-107 with Enhanced Antibacterial Potency.
Cruz JC; Iorio M; Monciardini P; Simone M; Brunati C; Gaspari E; Maffioli SI; Wellington E; Sosio M; Donadio S
J Nat Prod; 2015 Nov; 78(11):2642-7. PubMed ID: 26512731
[TBL] [Abstract][Full Text] [Related]
4. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.
Castiglione F; Lazzarini A; Carrano L; Corti E; Ciciliato I; Gastaldo L; Candiani P; Losi D; Marinelli F; Selva E; Parenti F
Chem Biol; 2008 Jan; 15(1):22-31. PubMed ID: 18215770
[TBL] [Abstract][Full Text] [Related]
5. Microbisporicin gene cluster reveals unusual features of lantibiotic biosynthesis in actinomycetes.
Foulston LC; Bibb MJ
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13461-6. PubMed ID: 20628010
[TBL] [Abstract][Full Text] [Related]
6. A relA-dependent regulatory cascade for auto-induction of microbisporicin production in Microbispora corallina.
Fernández-Martínez LT; Gomez-Escribano JP; Bibb MJ
Mol Microbiol; 2015 Aug; 97(3):502-14. PubMed ID: 25939852
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the molecular physiology of lantibiotic NAI-107 production in Microbispora ATCC-PTA-5024.
Gallo G; Renzone G; Palazzotto E; Monciardini P; Arena S; Faddetta T; Giardina A; Alduina R; Weber T; Sangiorgi F; Russo A; Spinelli G; Sosio M; Scaloni A; Puglia AM
BMC Genomics; 2016 Jan; 17():42. PubMed ID: 26754974
[TBL] [Abstract][Full Text] [Related]
8. Family of class I lantibiotics from actinomycetes and improvement of their antibacterial activities.
Maffioli SI; Monciardini P; Catacchio B; Mazzetti C; Münch D; Brunati C; Sahl HG; Donadio S
ACS Chem Biol; 2015 Apr; 10(4):1034-42. PubMed ID: 25574687
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains.
Simone M; Monciardini P; Gaspari E; Donadio S; Maffioli SI
J Antibiot (Tokyo); 2013 Feb; 66(2):73-8. PubMed ID: 23168402
[TBL] [Abstract][Full Text] [Related]
10. Inorganic phosphate is a trigger factor for Microbispora sp. ATCC-PTA-5024 growth and NAI-107 production.
Giardina A; Alduina R; Gallo G; Monciardini P; Sosio M; Puglia AM
Microb Cell Fact; 2014 Oct; 13():133. PubMed ID: 25300322
[TBL] [Abstract][Full Text] [Related]
11. Feed-forward regulation of microbisporicin biosynthesis in Microbispora corallina.
Foulston L; Bibb M
J Bacteriol; 2011 Jun; 193(12):3064-71. PubMed ID: 21478362
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on lantibiotic discovery - where have we failed and what improvements are required?
Sandiford SK
Expert Opin Drug Discov; 2015 Apr; 10(4):315-20. PubMed ID: 25697059
[TBL] [Abstract][Full Text] [Related]
13. Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics.
Stegmann E; Frasch HJ; Kilian R; Pozzi R
Int J Med Microbiol; 2015 Feb; 305(2):190-5. PubMed ID: 25601631
[TBL] [Abstract][Full Text] [Related]
14. Epidermin and gallidermin: Staphylococcal lantibiotics.
Götz F; Perconti S; Popella P; Werner R; Schlag M
Int J Med Microbiol; 2014 Jan; 304(1):63-71. PubMed ID: 24119540
[TBL] [Abstract][Full Text] [Related]
15. Cloning and analysis of the planosporicin lantibiotic biosynthetic gene cluster of Planomonospora alba.
Sherwood EJ; Hesketh AR; Bibb MJ
J Bacteriol; 2013 May; 195(10):2309-21. PubMed ID: 23475977
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the congeners in the lantibiotic NAI-107 complex.
Maffioli SI; Iorio M; Sosio M; Monciardini P; Gaspari E; Donadio S
J Nat Prod; 2014 Jan; 77(1):79-84. PubMed ID: 24422756
[TBL] [Abstract][Full Text] [Related]
17. Distinct mechanisms contribute to immunity in the lantibiotic NAI-107 producer strain Microbispora ATCC PTA-5024.
Pozzi R; Coles M; Linke D; Kulik A; Nega M; Wohlleben W; Stegmann E
Environ Microbiol; 2016 Jan; 18(1):118-32. PubMed ID: 25923468
[TBL] [Abstract][Full Text] [Related]
18. Lantibiotics produced by Actinobacteria and their potential applications (a review).
Gomes KM; Duarte RS; de Freire Bastos MDC
Microbiology (Reading); 2017 Feb; 163(2):109-121. PubMed ID: 28270262
[TBL] [Abstract][Full Text] [Related]
19. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
20. Thusin, a Novel Two-Component Lantibiotic with Potent Antimicrobial Activity against Several Gram-Positive Pathogens.
Xin B; Zheng J; Liu H; Li J; Ruan L; Peng D; Sajid M; Sun M
Front Microbiol; 2016; 7():1115. PubMed ID: 27486447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
